AACI Joins Colleagues in Statement on Immigration

In response to the Presidential Executive Order on Entry into the U.S., AACI has joined other cancer and disease organizations in expressing concern about the Trump Administration’s move to deny U.S. entry to people who bring unique expertise to the practice of medicine and the conduct of cancer and biomedical research.

“Our nation’s cancer centers are home to innovative minds from around the world. These individuals bring research and techniques to our great country that aid our institutions in the care for patients battling cancer," said AACI President Dr. Stanton Gerson. "Denying these valuable individuals admittance to the U.S. will only hinder our ability to make further progress in cancer research.”

The joint statement, released by AACI, the American Association for Cancer Research (AACR), the American Society for Radiation Oncology (ASTRO), the American Society of Hematology (ASH), The American Society of Pediatric Hematology/Oncology (ASPHO), and the LUNGevity Foundation, reads in part:

“The benefits of scientific collaborations are amplified by our diversity. Limiting the exchange of ideas, practices, and data across cultures has the potential to significantly retard scientific progress and adversely affect public health. Any loss of researchers and physicians will render the United States less competitive over time, and our traditionally strong research institutions and the patients they serve will be negatively affected.”

In related news, Airbnb CEO Brian Chesky announced that Airbnb is offering free accommodations to those affected by the recent U.S. travel ban. Click to read Mr. Chesky’s blog post.